| Year |
Citation |
Score |
| 2024 |
Boutelle AM, Mabene AR, Yao D, Xu H, Wang M, Tang YJ, Lopez SS, Sinha S, Demeter J, Cheng R, Benard BA, Valente LJ, Drainas AP, Fischer M, Majeti R, ... ... Attardi LD, et al. Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network. Biorxiv : the Preprint Server For Biology. PMID 39345444 DOI: 10.1101/2024.09.17.612743 |
0.435 |
|
| 2024 |
Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, ... ... Attardi LD, et al. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nature Medicine. PMID 38816611 DOI: 10.1038/s41591-024-03054-y |
0.724 |
|
| 2024 |
Morral C, Ayyaz A, Kuo HC, Fink M, Verginadis II, Daniel AR, Burner DN, Driver LM, Satow S, Hasapis S, Ghinnagow R, Luo L, Ma Y, Attardi LD, Koumenis C, et al. p53 promotes revival stem cells in the regenerating intestine after severe radiation injury. Nature Communications. 15: 3018. PMID 38589357 DOI: 10.1038/s41467-024-47124-8 |
0.36 |
|
| 2023 |
Mangoli A, Wu S, Liu HQ, Aksu M, Jain V, Foreman BE, Regal JA, Weidenhammer LB, Stewart CE, Guerra Garcia ME, Hocke E, Abramson K, Williams NT, Luo L, Deland K, ... Attardi L, et al. ( ) disruption sensitizes spatially-directed H3.3K27M/TP53 diffuse midline gliomas to radiation therapy. Biorxiv : the Preprint Server For Biology. PMID 37904990 DOI: 10.1101/2023.10.18.562892 |
0.319 |
|
| 2023 |
Kaiser AM, Gatto A, Hanson KJ, Zhao RL, Raj N, Ozawa MG, Seoane JA, Bieging-Rolett KT, Wang M, Li I, Trope WL, Liou DZ, Shrager JB, Plevritis SK, Newman AM, ... ... Attardi LD, et al. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature. PMID 37468633 DOI: 10.1038/s41586-023-06253-8 |
0.412 |
|
| 2023 |
Morral C, Ayyaz A, Kuo HC, Fink M, Verginadis I, Daniel AR, Burner DN, Driver LM, Satow S, Hasapis S, Ghinnagow R, Luo L, Ma Y, Attardi LD, Koumenis C, et al. p53 promotes revival stem cells in the regenerating intestine after severe radiation injury. Biorxiv : the Preprint Server For Biology. PMID 37162959 DOI: 10.1101/2023.04.27.538576 |
0.339 |
|
| 2023 |
Mello SS, Flowers BM, Mazur PK, Lee JJ, Müller F, Denny SK, Ferreira S, Hanson K, Kim SK, Greenleaf WJ, Wood LD, Attardi LD. Multifaceted role for p53 in pancreatic cancer suppression. Proceedings of the National Academy of Sciences of the United States of America. 120: e2211937120. PMID 36848578 DOI: 10.1073/pnas.2211937120 |
0.457 |
|
| 2022 |
Raj N, Wang M, Seoane JA, Zhao RL, Kaiser AM, Moonie NA, Demeter J, Boutelle AM, Kerr CH, Mulligan AS, Moffatt C, Zeng SX, Lu H, Barna M, Curtis C, ... ... Attardi LD, et al. The Mettl3 epitranscriptomic writer amplifies p53 stress responses. Molecular Cell. PMID 35512709 DOI: 10.1016/j.molcel.2022.04.010 |
0.437 |
|
| 2022 |
Kuo HC, Luo L, Ma Y, Williams NT, da Silva Campos L, Attardi LD, Lee CL, Kirsch DG. The p53 Transactivation Domain 1-Dependent Response to Acute DNA Damage in Endothelial Cells Protects against Radiation-Induced Cardiac Injury. Radiation Research. PMID 35512345 DOI: 10.1667/RADE-22-00001.1 |
0.384 |
|
| 2021 |
Wang M, Attardi LD. A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications. Annual Review of Pathology. PMID 34699262 DOI: 10.1146/annurev-pathol-042320-025840 |
0.409 |
|
| 2021 |
Tiu GC, Kerr CH, Forester CM, Krishnarao PS, Rosenblatt HD, Raj N, Lantz TC, Zhulyn O, Bowen ME, Shokat L, Attardi LD, Ruggero D, Barna M. A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies. Developmental Cell. PMID 34242585 DOI: 10.1016/j.devcel.2021.06.013 |
0.331 |
|
| 2021 |
Bieging-Rolett KT, Attardi LD. Zmat3 splices together p53-dependent tumor suppression. Molecular & Cellular Oncology. 8: 1898523. PMID 34027039 DOI: 10.1080/23723556.2021.1898523 |
0.342 |
|
| 2021 |
Bowen ME, Mulligan AS, Sorayya A, Attardi LD. Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects. Cell Death and Differentiation. PMID 33574585 DOI: 10.1038/s41418-021-00738-7 |
0.456 |
|
| 2021 |
Valente LJ, Attardi LD. P53 orchestrates a complex symphony of cellular processes during oncosuppression. Molecular & Cellular Oncology. 8: 1852066. PMID 33553606 DOI: 10.1080/23723556.2020.1852066 |
0.383 |
|
| 2021 |
Boutelle AM, Attardi LD. p53 and Tumor Suppression: It Takes a Network. Trends in Cell Biology. PMID 33518400 DOI: 10.1016/j.tcb.2020.12.011 |
0.422 |
|
| 2020 |
Bieging-Rolett KT, Kaiser AM, Morgens DW, Boutelle AM, Seoane JA, Van Nostrand EL, Zhu C, Houlihan SL, Mello SS, Yee BA, McClendon J, Pierce SE, Winters IP, Wang M, Connolly AJ, ... ... Attardi LD, et al. Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program. Molecular Cell. 80: 452-469.e9. PMID 33157015 DOI: 10.1016/j.molcel.2020.10.022 |
0.571 |
|
| 2020 |
Valente LJ, Tarangelo A, Li AM, Naciri M, Raj N, Boutelle AM, Li Y, Mello SS, Bieging-Rolett K, DeBerardinis RJ, Ye J, Dixon SJ, Attardi LD. p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen. The Journal of Cell Biology. 219. PMID 32886745 DOI: 10.1083/Jcb.201908212 |
0.44 |
|
| 2020 |
Flowers B, Xu H, Hanson K, Curtis C, Vogel H, Wood L, Attardi LD. Abstract IA14: Deconstructing the origins of PDAC development Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-Ia14 |
0.376 |
|
| 2019 |
Bowen ME, McClendon J, Long HK, Sorayya A, Van Nostrand JL, Wysocka J, Attardi LD. The Spatiotemporal Pattern and Intensity of p53 Activation Dictates Phenotypic Diversity in p53-Driven Developmental Syndromes. Developmental Cell. PMID 31178404 DOI: 10.1016/J.Devcel.2019.05.015 |
0.398 |
|
| 2019 |
Jacobs SBR, Van Nostrand JL, Bowen ME, Baker JC, Attardi LD. Siva plays a critical role in mouse embryonic development. Cell Death and Differentiation. PMID 31164717 DOI: 10.1038/S41418-019-0358-X |
0.38 |
|
| 2019 |
Bowen ME, Attardi LD. The role of p53 in developmental syndromes. Journal of Molecular Cell Biology. PMID 30624728 DOI: 10.1093/Jmcb/Mjy087 |
0.396 |
|
| 2019 |
Flowers B, Xu H, Hanson K, Curtis C, Vogel H, Wood LD, Attardi LD. Abstract I15: Deciphering the origins of PDAC development Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-I15 |
0.344 |
|
| 2019 |
Flowers BM, Xu H, Hanson K, Curtis C, Vogel H, Wood LD, Attardi LD. Abstract A15: Elucidating the role of p53 in the cellular origins of pancreatic cancer development Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A15 |
0.449 |
|
| 2018 |
Kaiser AM, Attardi LD. Deconstructing networks of p53-mediated tumor suppression in vivo. Cell Death and Differentiation. 25: 93-103. PMID 31745313 DOI: 10.1038/cdd.2017.171 |
0.44 |
|
| 2018 |
Mello SS, Attardi LD. Neat-en-ing up our understanding of p53 pathways in tumor suppression. Cell Cycle (Georgetown, Tex.). PMID 29895201 DOI: 10.1080/15384101.2018.1464835 |
0.395 |
|
| 2018 |
Calo E, Gu B, Bowen ME, Aryan F, Zalc A, Liang J, Flynn RA, Swigut T, Chang HY, Attardi LD, Wysocka J. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders. Nature. PMID 29364875 DOI: 10.1038/Nature25449 |
0.333 |
|
| 2018 |
Tarangelo A, Magtanong L, Bieging-Rolett KT, Li Y, Ye J, Attardi LD, Dixon SJ. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells. Cell Reports. 22: 569-575. PMID 29346757 DOI: 10.1016/j.celrep.2017.12.077 |
0.39 |
|
| 2018 |
Mello SS, Bieging-Rolett K, Kaiser A, Valente EJ, Raj N, McClendon J, Flowers BM, Morgens DW, Bassik MC, Attardi LD. Abstract IA07: Deconstructing p53 pathways in tumor suppression Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-Ia07 |
0.483 |
|
| 2017 |
Mello SS, Attardi LD. Deciphering p53 signaling in tumor suppression. Current Opinion in Cell Biology. 51: 65-72. PMID 29195118 DOI: 10.1016/j.ceb.2017.11.005 |
0.452 |
|
| 2017 |
Kaiser AM, Attardi LD. Deconstructing networks of p53-mediated tumor suppression in vivo. Cell Death and Differentiation. PMID 29099489 DOI: 10.1038/cdd.2017.171 |
0.449 |
|
| 2017 |
Mello SS, Valente LJ, Raj N, Seoane JA, Flowers BM, McClendon J, Bieging-Rolett KT, Lee J, Ivanochko D, Kozak MM, Chang DT, Longacre TA, Koong AC, Arrowsmith CH, Kim SK, ... ... Attardi LD, et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell. 32: 460-473.e6. PMID 29017057 DOI: 10.1016/J.Ccell.2017.09.007 |
0.408 |
|
| 2017 |
Mello SS, Sinow C, Raj N, Mazur PK, Bieging-Rolett K, Broz DK, Imam JFC, Vogel H, Wood LD, Sage J, Hirose T, Nakagawa S, Rinn J, Attardi LD. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes & Development. PMID 28698299 DOI: 10.1101/Gad.284661.116 |
0.676 |
|
| 2017 |
Filipescu D, Naughtin M, Podsypanina K, Lejour V, Wilson L, Gurard-Levin ZA, Orsi GA, Simeonova I, Toufektchan E, Attardi LD, Toledo F, Almouzni G. Essential role for centromeric factors following p53 loss and oncogenic transformation. Genes & Development. PMID 28356341 DOI: 10.1101/Gad.290924.116 |
0.488 |
|
| 2017 |
Van Nostrand JL, Bowen ME, Vogel H, Barna M, Attardi LD. The p53 family members have distinct roles during mammalian embryonic development. Cell Death and Differentiation. PMID 28211873 DOI: 10.1038/Cdd.2016.128 |
0.419 |
|
| 2017 |
Simmons A, Kong C, Eyben Rv, Attardi L, Ma X, Le Q, Nathan C. Abstract 62: Loss of PERP p53/p63 target gene may indicate tumorigenesis at the margin and local recurrence Clinical Cancer Research. 23: 62-62. DOI: 10.1158/1557-3265.Aacrahns17-62 |
0.394 |
|
| 2016 |
Raj N, Attardi LD. The Transactivation Domains of the p53 Protein. Cold Spring Harbor Perspectives in Medicine. PMID 27864306 DOI: 10.1101/Cshperspect.A026047 |
0.386 |
|
| 2016 |
Schmitt AM, Garcia JT, Hung T, Flynn RA, Shen Y, Qu K, Payumo AY, Peres-da-Silva A, Broz DK, Baum R, Guo S, Chen JK, Attardi LD, Chang HY. An inducible long noncoding RNA amplifies DNA damage signaling. Nature Genetics. PMID 27668660 DOI: 10.1038/Ng.3673 |
0.34 |
|
| 2016 |
Jackson PK, Attardi LD. p73 and FoxJ1: Programming Multiciliated Epithelia. Trends in Cell Biology. PMID 26988441 DOI: 10.1016/J.Tcb.2016.03.001 |
0.436 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin J, Abeliovich H, Arozena AA, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Attardi LD, et al. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Autophagy. 12: 443-443. PMID 26902590 DOI: 10.1080/15548627.2016.1147886 |
0.539 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Attardi LD, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.582 |
|
| 2016 |
Bieging-Rolett KT, Johnson TM, Brady CA, Beaudry VG, Pathak N, Han S, Attardi LD. p19(Arf) is required for the cellular response to chronic DNA damage. Oncogene. PMID 26725325 DOI: 10.1038/onc.2015.490 |
0.342 |
|
| 2015 |
Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, ... ... Attardi LD, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nature Medicine. PMID 26390243 DOI: 10.1038/Nm.3952 |
0.761 |
|
| 2015 |
Younger ST, Kenzelmann-Broz D, Jung H, Attardi LD, Rinn JL. Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage. Nucleic Acids Research. 43: 4447-62. PMID 25883152 DOI: 10.1093/nar/gkv284 |
0.403 |
|
| 2015 |
Van Nostrand JL, Brisac A, Mello SS, Jacobs SB, Luong R, Attardi LD. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development. Cancer Discovery. 5: 622-35. PMID 25813352 DOI: 10.1158/2159-8290.CD-14-0921 |
0.434 |
|
| 2015 |
Bieging KT, Attardi LD. A piece of the p53 puzzle Nature. 520: 37-38. PMID 25799989 DOI: 10.1038/Nature14374 |
0.397 |
|
| 2015 |
Jiang D, LaGory EL, Kenzelmann Brož D, Bieging KT, Brady CA, Link N, Abrams JM, Giaccia AJ, Attardi LD. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function. Cell Reports. 10: 1096-109. PMID 25704813 DOI: 10.1016/J.Celrep.2015.01.043 |
0.42 |
|
| 2014 |
Van Nostrand JL, Attardi LD. Guilty as CHARGED: p53's expanding role in disease. Cell Cycle (Georgetown, Tex.). 13: 3798-807. PMID 25483057 DOI: 10.4161/15384101.2014.987627 |
0.379 |
|
| 2014 |
Van Nostrand JL, Brady CA, Jung H, Fuentes DR, Kozak MM, Johnson TM, Lin CY, Lin CJ, Swiderski DL, Vogel H, Bernstein JA, Attié-Bitach T, Chang CP, Wysocka J, Martin DM, ... Attardi LD, et al. Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature. 514: 228-32. PMID 25119037 DOI: 10.1038/Nature13585 |
0.394 |
|
| 2014 |
Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression Nature Reviews Cancer. 14: 359-370. PMID 24739573 DOI: 10.1038/Nrc3711 |
0.394 |
|
| 2014 |
Garcia PB, Attardi LD. Illuminating p53 function in cancer with genetically engineered mouse models. Seminars in Cell & Developmental Biology. 27: 74-85. PMID 24394915 DOI: 10.1016/j.semcdb.2013.12.014 |
0.447 |
|
| 2013 |
Raj N, Attardi LD. Tumor suppression: P53 alters immune surveillance to restrain liver cancer Current Biology. 23: R527-R530. PMID 23787049 DOI: 10.1016/J.Cub.2013.04.076 |
0.366 |
|
| 2013 |
Mello SS, Attardi LD. Not all p53 gain-of-function mutants are created equal Cell Death and Differentiation. 20: 855-857. PMID 23749181 DOI: 10.1038/cdd.2013.53 |
0.304 |
|
| 2013 |
Kenzelmann Broz D, Mello SS, Bieging KT, Jiang D, Dusek RL, Brady CA, Sidow A, Attardi LD. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses Genes and Development. 27: 1016-1031. PMID 23651856 DOI: 10.1101/Gad.212282.112 |
0.469 |
|
| 2013 |
Attardi LD, Sage J. RB goes mitochondrial Genes and Development. 27: 975-979. PMID 23651852 DOI: 10.1101/Gad.219451.113 |
0.586 |
|
| 2013 |
Jiang D, Attardi LD. Engaging the p53 metabolic brake drives senescence Cell Research. 23: 739-740. PMID 23478296 DOI: 10.1038/cr.2013.34 |
0.354 |
|
| 2013 |
Kong CS, Cao H, Kwok S, Nguyen CM, Jordan RC, Beaudry VG, Attardi LD, Le QT. Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 115: 95-103. PMID 23217540 DOI: 10.1016/j.oooo.2012.10.017 |
0.462 |
|
| 2013 |
Brady CA, Broz DK, Jiang D, Mello SS, Bieging K, Johnson TM, Jarvis LA, Kozak MM, Basak S, Attardi LD. Abstract IA4: Deconstructing p53 pathways in vivo Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Ia4 |
0.475 |
|
| 2012 |
Dusek RL, Bascom JL, Vogel H, Baron S, Borowsky AD, Bissell MJ, Attardi LD. Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer. Breast Cancer Research : Bcr. 14: R65. PMID 22515648 DOI: 10.1186/Bcr3171 |
0.39 |
|
| 2012 |
Bieging KT, Attardi LD. Deconstructing p53 transcriptional networks in tumor suppression Trends in Cell Biology. 22: 97-106. PMID 22154076 DOI: 10.1016/J.Tcb.2011.10.006 |
0.453 |
|
| 2012 |
Sage J, Attardi L, van Dyke T. Roles of p53 and pRB tumor suppressor networks in human cancer: Insight from studies in the engineered mouse Genetically Engineered Mice For Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. 293-308. DOI: 10.1007/978-0-387-69805-2_14 |
0.544 |
|
| 2011 |
Jiang D, Brady CA, Johnson TM, Lee EY, Park EJ, Scott MP, Attardi LD. Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages. Proceedings of the National Academy of Sciences of the United States of America. 108: 17123-8. PMID 21969549 DOI: 10.1073/pnas.1111245108 |
0.459 |
|
| 2011 |
Brady CA, Jiang D, Mello SS, Johnson TM, Jarvis LA, Kozak MM, Kenzelmann Broz D, Basak S, Park EJ, McLaughlin ME, Karnezis AN, Attardi LD. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell. 145: 571-83. PMID 21565614 DOI: 10.1016/J.Cell.2011.03.035 |
0.461 |
|
| 2011 |
Renault VM, Thekkat PU, Hoang KL, White JL, Brady CA, Kenzelmann Broz D, Venturelli OS, Johnson TM, Oskoui PR, Xuan Z, Santo EE, Zhang MQ, Vogel H, Attardi LD, Brunet A. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene. 30: 3207-21. PMID 21423206 DOI: 10.1038/Onc.2011.35 |
0.483 |
|
| 2011 |
Jheon AH, Mostowfi P, Snead ML, Ihrie RA, Sone E, Pramparo T, Attardi LD, Klein OD. PERP regulates enamel formation via effects on cell-cell adhesion and gene expression Journal of Cell Science. 124: 745-754. PMID 21285247 DOI: 10.1242/Jcs.078071 |
0.655 |
|
| 2011 |
Le Q, Cao H, Kwok S, Jordan R, Beaudry V, Attardi L, Kong C. Loss of the p53/p63 Target PERP is an Early Event in Oral Cavity Carcinogenesis and Correlates with Higher Local Failure Rate in These Tumors International Journal of Radiation Oncology*Biology*Physics. 81: S756. DOI: 10.1016/J.IJROBP.2011.06.1257 |
0.315 |
|
| 2010 |
Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian BC, Attardi LD. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. Plos Genetics. 6: e1001168. PMID 20975948 DOI: 10.1371/journal.pgen.1001168 |
0.376 |
|
| 2010 |
Brady CA, Attardi LD. p53 at a glance Journal of Cell Science. 123: 2527-2532. PMID 20940128 DOI: 10.1242/jcs.064501 |
0.374 |
|
| 2010 |
Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, Attardi LD, Regev A, Lander ES, Jacks T, Rinn JL. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 142: 409-19. PMID 20673990 DOI: 10.1016/J.Cell.2010.06.040 |
0.673 |
|
| 2010 |
Beaudry VG, Ihrie RA, Jacobs SB, Nguyen B, Pathak N, Park E, Attardi LD. Loss of the desmosomal component perp impairs wound healing in vivo. Dermatology Research and Practice. 2010: 759731. PMID 20628490 DOI: 10.1155/2010/759731 |
0.596 |
|
| 2010 |
Brož DK, Attardi LD. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models Carcinogenesis. 31: 1311-1318. PMID 20097732 DOI: 10.1093/carcin/bgp331 |
0.466 |
|
| 2009 |
Beaudry VG, Attardi LD. SKP-ing TAp63: Stem Cell Depletion, Senescence, and Premature Aging Cell Stem Cell. 5: 1-2. PMID 19570504 DOI: 10.1016/j.stem.2009.06.015 |
0.304 |
|
| 2008 |
Basak S, Jacobs SB, Krieg AJ, Pathak N, Zeng Q, Kaldis P, Giaccia AJ, Attardi LD. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Molecular Cell. 30: 303-14. PMID 18471976 DOI: 10.1016/J.Molcel.2008.04.002 |
0.431 |
|
| 2008 |
Johnson TM, Meade K, Pathak N, Marques MR, Attardi LD. Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence Proceedings of the National Academy of Sciences of the United States of America. 105: 1215-1220. PMID 18216268 DOI: 10.1073/pnas.0706764105 |
0.485 |
|
| 2008 |
Jarvis L, Johnson T, Attardi L. Full Transcriptional Activation of p53 Target Genes is Not Necessary for Suppression of K-ras Induced Lung Adenocarcinomas International Journal of Radiation Oncology*Biology*Physics. 72: S21-S22. DOI: 10.1016/J.Ijrobp.2008.06.814 |
0.365 |
|
| 2007 |
Wijnhoven SWP, Speksnijder EN, Liu X, Zwart E, VanOostrom CTM, Beems RB, Hoogervorst EM, Schaap MM, Attardi LD, Jacks T, Van Steeg H, Jonkers J, De Vries A. Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage Cancer Research. 67: 4648-4656. PMID 17510390 DOI: 10.1158/0008-5472.Can-06-4681 |
0.686 |
|
| 2007 |
Jacobs SB, Basak S, Murray JI, Pathak N, Attardi LD. Siva is an apoptosis-selective p53 target gene important for neuronal cell death. Cell Death and Differentiation. 14: 1374-85. PMID 17464332 DOI: 10.1038/Sj.Cdd.4402128 |
0.367 |
|
| 2007 |
Carroll DK, Brugge JS, Attardi LD. p63, cell adhesion and survival Cell Cycle. 6: 255-261. PMID 17297292 DOI: 10.4161/Cc.6.3.3799 |
0.425 |
|
| 2006 |
Hammond EM, Mandell DJ, Salim A, Krieg AJ, Johnson TM, Shirazi HA, Attardi LD, Giaccia AJ. Genome-wide analysis of p53 under hypoxic conditions Molecular and Cellular Biology. 26: 3492-3504. PMID 16611991 DOI: 10.1128/Mcb.26.9.3492-3504.2006 |
0.46 |
|
| 2006 |
Johnson TM, Attardi LD. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice Cell Death and Differentiation. 13: 902-908. PMID 16557272 DOI: 10.1038/sj.cdd.4401902 |
0.314 |
|
| 2006 |
Ihrie RA, Bronson RT, Attardi LD. Adult mice lacking the p53/p63 target gene Perp are not predisposed to spontaneous tumorigenesis but display features of ectodermal dysplasia syndromes [2] Cell Death and Differentiation. 13: 1614-1618. PMID 16485031 DOI: 10.1038/Sj.Cdd.4401871 |
0.68 |
|
| 2006 |
Marques MR, Ihrie RA, Horner JS, Attardi LD. The requirement for Perp in postnatal viability and epithelial integrity reflects an intrinsic role in stratified epithelia Journal of Investigative Dermatology. 126: 69-73. PMID 16417219 DOI: 10.1038/Sj.Jid.5700032 |
0.618 |
|
| 2005 |
Marques MR, Horner JS, Ihrie RA, Bronson RT, Attardi LD. Mice lacking the p53/p63 target gene Perp are resistant to papilloma development Cancer Research. 65: 6551-6556. PMID 16061634 DOI: 10.1158/0008-5472.Can-05-0366 |
0.719 |
|
| 2005 |
Attardi LD, Donehower LA. Probing p53 biological functions through the use of genetically engineered mouse models Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 576: 4-21. PMID 16038709 DOI: 10.1016/j.mrfmmm.2004.08.022 |
0.418 |
|
| 2005 |
Ihrie RA, Attardi LD. A new perp in the lineup: Linking p63 and desmosomal adhesion Cell Cycle. 4: 873-876. PMID 15970683 DOI: 10.4161/Cc.4.7.1836 |
0.713 |
|
| 2005 |
Johnson TM, Attardi LD. p53QS: An old mutant teaches us new tricks Cell Cycle. 4: 731-734. PMID 15908788 |
0.467 |
|
| 2005 |
Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT, Mills AA, Attardi LD. Perp is a p63-regulated gene essential for epithelial integrity Cell. 120: 843-856. PMID 15797384 DOI: 10.1016/J.Cell.2005.01.008 |
0.714 |
|
| 2005 |
Johnson TM, Hammond EM, Giaccia A, Attardi LD. The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality Nature Genetics. 37: 145-152. PMID 15654339 DOI: 10.1038/Ng1498 |
0.478 |
|
| 2005 |
Attardi LD. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: Lessons from mouse models Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 569: 145-157. PMID 15603759 DOI: 10.1016/j.mrfmmm.2004.04.019 |
0.388 |
|
| 2004 |
Bruins W, Zwart E, Attardi LD, Iwakuma T, Hoogervorst EM, Beems RB, Miranda B, Van Oostrom CTM, Van Den Berg J, Van Den Aardweg GJ, Lozano G, Van Steeg H, Jacks T, De Vries A. Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389 Molecular and Cellular Biology. 24: 8884-8894. PMID 15456863 DOI: 10.1128/Mcb.24.20.8884-8894.2004 |
0.685 |
|
| 2004 |
Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW. Developmental context determines latency of MYC-induced tumorigenesis Plos Biology. 2. PMID 15455033 DOI: 10.1371/Journal.Pbio.0020332 |
0.676 |
|
| 2004 |
Attardi LD, De Vries A, Jacks T. Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer Oncogene. 23: 973-980. PMID 14749764 DOI: 10.1038/Sj.Onc.1207026 |
0.68 |
|
| 2004 |
Ihrie RA, Attardi LD. Perp-etrating p53-dependent apoptosis Cell Cycle. 3: 267-269. PMID 14726658 DOI: 10.4161/Cc.3.3.722 |
0.738 |
|
| 2004 |
Attardi LD, DePinho RA. Conquering the complexity of p53. Nature Genetics. 36: 7-8. PMID 14702030 DOI: 10.1038/Ng0104-7 |
0.354 |
|
| 2003 |
Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T. Multiple Response Elements and Differential p53 Binding Control Perp Expression during Apoptosis Molecular Cancer Research. 1: 1048-1057. PMID 14707288 |
0.711 |
|
| 2003 |
Ihrie RA, Reczek E, Horner JS, Khachatrian L, Sage J, Jacks T, Attardi LD. Perp Is a Mediator of p53-Dependent Apoptosis in Diverse Cell Types Current Biology. 13: 1985-1990. PMID 14614825 DOI: 10.1016/J.Cub.2003.10.055 |
0.806 |
|
| 2000 |
Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E, Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization Genes and Development. 14: 3037-3050. PMID 11114892 DOI: 10.1101/Gad.843200 |
0.758 |
|
| 2000 |
Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW, Jacks T. PERP, an apoptosis-associated target of p53, in a novel member of the PMP-22/gas3 family Genes and Development. 14: 704-718. PMID 10733530 DOI: 10.1101/Gad.14.6.704 |
0.762 |
|
| 1999 |
Attardi LD, Jacks T. The role of p53 in tumour suppression: Lessons from mouse models Cellular and Molecular Life Sciences. 55: 48-63. PMID 10065151 DOI: 10.1007/S000180050269 |
0.704 |
|
| 1998 |
Attardi L, Brugarolas J, Heinrichs A. HDAC, a key to pRb tumour suppression? Trends in Cell Biology. 8: 182. DOI: 10.1016/S0962-8924(98)01277-X |
0.459 |
|
| 1997 |
Jones JM, Attardi L, Godley LA, Laucirica R, Medina D, Jacks T, Varmus HE, Donehower LA. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 8: 829-38. PMID 9269892 |
0.72 |
|
| 1996 |
Attardi LD, Lowe SW, Brugarolas J, Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis Embo Journal. 15: 3693-3701. PMID 8758936 |
0.496 |
|
| 1996 |
Attardi LD, Lowe SW, Brugarolas J, Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. The Embo Journal. 15: 3693-3701. DOI: 10.1002/J.1460-2075.1996.Tb00739.X |
0.785 |
|
| 1995 |
Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T. A subset of p53-deficient embryos exhibit exencephaly Nature Genetics. 10: 175-180. PMID 7663512 DOI: 10.1038/Ng0695-175 |
0.715 |
|
| Show low-probability matches. |